V. Bres et al., Pharmacological characterization of volume-sensitive, taurine permeable anion channels in rat supraoptic glial cells, BR J PHARM, 130(8), 2000, pp. 1976-1982
1 To characterize the volume-sensitive, osmolyte permeable anion channels r
esponsible for the osmodependent release of taurine from supraoptic nucleus
(SON) astrocytes, we investigated the pharmacological properties of the [H
-3]-taurine efflux from acutely isolated SON.
2 Taurine release induced by hypotonic stimulus (250 mosmol l(-1)) was not
antagonized by the taurine transporter blocker guanidinoethyl sulphonate, c
onfirming the lack of implication of the transporter.
3 The osmodependent release of taurine was blocked by a variety of Cl- chan
nel inhibitors with the order of potency: NPPB > niflumic acid > DPC > DIDS
>ATP. On the other hand, release of taurine was only weakly affected by ot
her compounds (dideoxyforskolin, 4-bromophenacyl bromide, mibefradil) known
to block volume-activated anion channels in other cell preparations, and w
as completely insensitive to tamoxifen, a broad inhibitor of these channels
.
4 Although the molecular identity of volume-sensitive anion channels is not
firmly established, a few genes have been postulated as potential candidat
es to encode such channels. We checked the expression in the SON of three o
f them, ClC3, phospholemman and VDAC(1), and found that the transcripts of
these genes are found in SON neurons, but not in astrocytes. Similar observ
ation was previously reported for ClC2.
5 In conclusion, the osmodependent taurine permeable channels of SON astroc
ytes display a particular pharmacological profile, suggesting the expressio
n of a particular type or subtype of volume-sensitive anion channel, which
is likely to be formed by yet unidentified proteins.